COMPOSITION AND KIT FOR DIAGNOSING BREAST CANCER INCLUDING POLYNUCLEOTIDE WITHIN VESICLE, AND METHOD OF DIAGNOSING BREAST CANCER USING THE SAME
    7.
    发明申请
    COMPOSITION AND KIT FOR DIAGNOSING BREAST CANCER INCLUDING POLYNUCLEOTIDE WITHIN VESICLE, AND METHOD OF DIAGNOSING BREAST CANCER USING THE SAME 有权
    用于诊断包括在囊内的多核苷酸的乳腺癌的组合物和试剂盒,以及使用该方法诊断乳腺癌的方法

    公开(公告)号:US20140178885A1

    公开(公告)日:2014-06-26

    申请号:US14132964

    申请日:2013-12-18

    CPC classification number: C12Q1/6886 C12Q2600/158 C12Q2600/178

    Abstract: A breast cancer diagnostic composition and kit, and methods of diagnosing breast cancer or acquiring information for breast cancer diagnosis by using the composition or kit are provided. The composition or kit includes a polynucleotide that is the same as or complementary to at least one microRNA (miRNA) selected from the group consisting of hsa-miR-126, hsa-miR-23a, hsa-miR-24, hsa-miR-19b, hsa-miR-103, hsa-miR-142-3p, hsa-miR-144, hsa-miR-15a, hsa-miR-185, hsa-miR-93, and hsa-miR-30c in a vesicle, or a fragment of the microRNA.

    Abstract translation: 提供乳腺癌诊断组合物和试剂盒,以及通过使用该组合物或试剂盒诊断乳腺癌或获取乳腺癌诊断信息的方法。 该组合物或试剂盒包括与选自hsa-miR-126,hsa-miR-23a,hsa-miR-24,hsa-miR- 19b,hsa-miR-103,hsa-miR-142-3p,hsa-miR-144,hsa-miR-15a,hsa-miR-185,hsa-miR-93和hsa-miR-30c, 或微小RNA的片段。

    Composition and kit for diagnosing breast cancer including polynucleotide within vesicle, and method of diagnosing breast cancer using the same
    8.
    发明授权
    Composition and kit for diagnosing breast cancer including polynucleotide within vesicle, and method of diagnosing breast cancer using the same 有权
    用于诊断乳腺癌的组合物和试剂盒,包括囊泡内的多核苷酸,以及使用该乳腺癌诊断乳腺癌的方法

    公开(公告)号:US09593379B2

    公开(公告)日:2017-03-14

    申请号:US14132964

    申请日:2013-12-18

    CPC classification number: C12Q1/6886 C12Q2600/158 C12Q2600/178

    Abstract: A breast cancer diagnostic composition and kit, and methods of diagnosing breast cancer or acquiring information for breast cancer diagnosis by using the composition or kit are provided. The composition or kit includes a polynucleotide that is the same as or complementary to at least one microRNA (miRNA) selected from the group consisting of hsa-miR-126, hsa-miR-23a, hsa-miR-24, hsa-miR-19b, hsa-miR-103, hsa-miR-142-3p, hsa-miR-144, hsa-miR-15a, hsa-miR-185, hsa-miR-93, and hsa-miR-30c in a vesicle, or a fragment of the microRNA.

    Abstract translation: 提供乳腺癌诊断组合物和试剂盒,以及通过使用该组合物或试剂盒诊断乳腺癌或获取乳腺癌诊断信息的方法。 该组合物或试剂盒包括与选自hsa-miR-126,hsa-miR-23a,hsa-miR-24,hsa-miR- 19b,hsa-miR-103,hsa-miR-142-3p,hsa-miR-144,hsa-miR-15a,hsa-miR-185,hsa-miR-93和hsa-miR-30c, 或微小RNA的片段。

Patent Agency Ranking